A TEXAS-OKLAHOMA PEDIATRIC NEURO-ONCOLOGY CONSORTIUM (TOPNOC) PHASE 2 STUDY OF VALPROIC ACID (VPA) AND RADIATION, FOLLOWED BY MAINTENANCE VPA AND BEVACIZUMAB IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR HIGH-GRADE GLIOMAS (HGG)

被引:0
|
作者
Su, Jack M. [1 ]
Murray, Jeffrey C. [2 ]
McNall-Knapp, Rene Y. [3 ]
Bowers, Daniel [4 ]
Shah, Shafqat [5 ]
Adesina, Adekunle M. [6 ]
Paulino, Arnold C. [7 ]
Li, Xiao-Nan [1 ]
Jo, Eunji [8 ]
Mo, Qianxing [8 ]
Hilsenbeck, Susan G. [8 ]
Jones, Jeremy Y. [9 ]
Baxter, Patricia A. [1 ]
Chintagumpala, Murali [1 ]
Blaney, SusanM. [1 ]
机构
[1] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[2] Cooks Childrens Med Ctr, Fortworth, TX USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA
[4] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[5] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol Oncol, San Antonio, TX 78229 USA
[6] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Baylor Coll Med, Dept Med Biostat & Bioinformat, Dan L Duncan Canc Ctr, Houston, TX 77030 USA
[9] Baylor Coll Med, Singleton Dept Radiol, Texas Childrens Hosp, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HG-49
引用
收藏
页码:58 / 58
页数:1
相关论文
共 20 条
  • [1] A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
    Su, Jack Meng-Fen
    Murray, Jeffrey C.
    McNall-Knapp, Rene Y.
    Bowers, Daniel C.
    Shah, Shafqat
    Adesina, Adekunle M.
    Paulino, Arnold C.
    Jo, Eunji
    Mo, Qianxing
    Baxter, Patricia A.
    Blaney, Susan M.
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 (06)
  • [2] Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report
    DeWire, Mariko
    Lazow, Margot
    Campagne, Olivia
    Leach, James
    Fuller, Christine
    Kumar, Shiva Senthil
    Stanek, Joseph
    de Blank, Peter
    Hummel, Trent R.
    Pillay-Smiley, Natasha
    Salloum, Ralph
    Stevenson, Charles B.
    Baxter, Patricia
    Gass, David
    Goldman, Stewart
    Leary, Sarah E. S.
    Carle, Adam
    Mikael, Leonie
    Crabtree, Dorothy
    Chaney, Brooklyn
    Lane, Adam
    Drissi, Rachid
    Stewart, Clinton F.
    Fouladi, Maryam
    [J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [3] A PILOT STUDY OF BEVACIZUMAB-BASED THERAPY IN CHILDREN AND YOUNG ADULTS WITH NEWLY-DIAGNOSED HIGH-GRADE GLIOMAS (HGG) AND DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)
    Dewire, Mariko
    Fouladi, Maryam
    Drissi, Rachid
    Chow, Lionel
    Goldman, Stewart
    Pai, Ahna
    Leach, James
    Lane, Adam
    Backus, Lori
    Grimme, Laurie
    Tabares, Jillian
    Kumar, Shiva
    Sobo, Matthew
    Hummel, Trent R.
    [J]. NEURO-ONCOLOGY, 2014, 16 : 12 - 12
  • [4] PHASE IB STUDY OF UNESBULIN (PTC596) IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
    Lazow, Margot A.
    Baxter, Patricia
    Stanek, Joseph
    Lane, Adam
    Rodriguez, Diana P.
    Kumar, Shiva Senthil
    Leach, James L.
    Mikael, Leonie
    Fuller, Christine
    Boue, Daniel R.
    Pierson, Christopher R.
    Thomas, Diana
    Breneman, John
    Palmer, Joshua
    Li, Xiao-Nan
    Salloum, Ralph
    Ashley, David
    de Blank, Peter
    Hwang, Eugene
    Leary, Sarah E. S.
    Plant, Ashley
    Crabtree, Dorothy
    Wahba, Mona
    Weetall, Marla
    Baird, John
    Leonard, Jeffrey
    Stewart, Clinton F.
    Mardis, Elaine
    Fouladi, Maryam
    Drissi, Rachid
    [J]. NEURO-ONCOLOGY, 2022, 24 : 36 - 36
  • [5] PHASE I STUDY OF RIBOCICLIB AND EVEROLIMUS POST-RADIOTHERAPY IN CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): UPDATED REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
    Lazow, Margot A.
    DeWire, Mariko
    Campagne, Olivia
    Leach, James L.
    Fuller, Christine
    Kumar, Shiva Senthil
    Stanek, Joseph
    de Blank, Peter
    Hummel, Trent R.
    Pillay-Smiley, Natasha
    Salloum, Ralph
    Stevenson, Charles B.
    Baxter, Patricia
    Gass, David
    Goldman, Stewart
    Leary, Sarah E. S.
    Carle, Adam
    Lane, Adam
    Drissi, Rachid
    Stewart, Clinton
    Fouladi, Maryam
    [J]. NEURO-ONCOLOGY, 2022, 24 : 36 - 37
  • [6] UPDATED FINDINGS FROM THE PHASE IB STUDY OF UNESBULIN (PTC596) IN CHILDREN WITH NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
    Lazow, Margot
    Baxter, Patricia
    Stanek, Joseph
    Rodriguez, Diana
    Kumar, Shiva Senthil
    Palmer, Joshua
    Leach, James
    Mikael, Leonie
    Thomas, Diana
    Fuller, Christine
    Boue, Daniel
    Pierson, Christopher
    Breneman, John
    Li, Xiao-Nan
    Salloum, Ralph
    Ashley, David
    De Blank, Peter
    Hwang, Eugene
    Leary, Sarah
    Plant, Ashley
    Fisher, Michael
    Chi, Susan
    Crabtree, Dorothy
    Murali, Mythili
    Weetall, Marla
    Rance, Mark
    Maliakal, Pius
    Baird, John
    D'Silva, Dhiren
    O'Keefe, Kylie
    Leonard, Jeffrey
    Stewart, Clinton
    Mardis, Elaine
    Fouladi, Maryam
    Drissi, Rachid
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [7] A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study
    Macy, Margaret E.
    Kieran, Mark W.
    Chi, Susan N.
    Cohen, Kenneth J.
    MacDonald, Tobey J.
    Smith, Amy A.
    Etzl, Michael M.
    Kuei, Michele C.
    Donson, Andrew M.
    Gore, Lia
    DiRenzo, Jennifer
    Trippett, Tanya M.
    Ostrovnaya, Irina
    Narendran, Aru
    Foreman, Nicholas K.
    Dunkel, Ira J.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [8] A PHASE I STUDY OF RIBOCICLIB AND EVEROLIMUS FOLLOWING RADIATION THERAPY IN CHILDREN WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB plus BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG)
    DeWire, Mariko
    Leach, James
    Fuller, Christine
    de Blank, Peter
    Hummel, Trent
    Pillay-Smiley, Natasha
    Salloum, Ralph
    Stevenson, Charles
    Drissi, Rachid
    Kumar, Shiva Senthil
    Baxter, Patricia
    Gass, David
    Goldman, Stewart
    Leary, Sarah
    Lane, Adam
    Campagne, Olivia
    Stewart, Clinton
    Fouladi, Maryam
    [J]. NEURO-ONCOLOGY, 2020, 22 : 307 - 307
  • [9] PHASE I STUDY OF CRENOLANIB (CP-868,596) ADMINISTERED DURING AND AFTER RADIATION THERAPY (RT) IN NEWLY-DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND RECURRENT HIGH GRADE GLIOMA, INCLUDING DIPG (HGG)
    Wetmore, Cynthia
    Broniscer, Alberto
    Wright, Karen
    Armstrong, Gregory
    Baker, Justin
    Pai-Panandiker, Atmaram
    Kun, Larry
    Patay, Zoltan
    Onar-Thomas, Arzu
    Ramachandran, Abhijit
    Turner, David
    Gajjar, Amar
    Stewart, Clinton
    [J]. NEURO-ONCOLOGY, 2012, 14 : 21 - 21
  • [10] First-in-pediatrics phase I study of crenolanib besylate (CP-868,596-26) administered during and after radiation therapy (RT) in newly diagnosed diffuse intrinsic pontine glioma (DIPG) and recurrent high-grade glioma (HGG).
    Wetmore, Cynthia
    Broniscer, Alberto
    Turner, David
    Wright, Karen D.
    Pal-Panandiker, Atmaram
    Kun, Larry E.
    Ramachandran, Abhijit
    Onar-Thomas, Arzu
    Huang, Jie
    Gajjar, Amar J.
    Baker, Suzanne
    Stewart, Clinton F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)